The HBV genotype assay classifies the virus present in the sample into one of nine recognized genotypes (A-I) via sequence analysis of the DNA polymerase gene. Disease progression and response to therapy may be influenced by genotype. In addition, the HBV genotype assay identifies and reports sequence polymorphisms in the basal core promotor (BCP) and coding regions of the HBV precore gene that result in either decreased levels, or complete absence, of HBeAg expression in chronically infected patients.
This assay may not be successful when the HBV viral load is <500 IU/mL.
Immediatley following collection, mix sample by inverting 5 times
Immediatley following collection, mix sample by inverting 5 times
Frozen (preferred) - 14 days
Polymerase chain reaction (PCR) amplification and DNA sequencing
An interpretive report will be provided